2026 Online Prescribers Summit

Objectives: Identify common adverse effects and contraindications associated with medical cannabis use across diverse patient populations. Apply evidence-based strategies to counsel patients, mitigate interaction risks, and incorporate reliable clinical resources into pharmacy practice. Analyze drug-drug interaction mechanisms between medical cannabis and commonly prescribed or dispensed medications. Summarize key trends and patterns in fatal and nonfatal overdoses in Mississippi, including implications for clinical practice Describe the structure, goals, and core services of the Mississippi State Department of Health Medications for Substance Use Disorders (MSUD) Program Explain the clinical benefits and evidence supporting medications for opioid use disorder (MOUD) Identify the impact of SUD-related stigma on patient outcomes and apply strategies to reduce stigma in clinical practice Demonstrate how to initiate referrals to the MSUD Program and integrate linkage-to-care and risk mitigation resources into clinical workflows Participants will be able to discuss comorbidity with ADHD, Sleep, Anxiety, Chronic Pain, & Weight Participants will be given prescribing practices when treating these comorbid conditions. Participants will be able to outline medication and non-medication therapeutic interventions. Participants will be able to discuss complexities and nuances of prescribing for these conditions. Participants will be able to explore practice policies and the referral process for these conditions.